These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34520398)

  • 1. Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment.
    Su X; Xu Y; Fox GC; Xiang J; Kwakwa KA; Davis JL; Belle JI; Lee WC; Wong WH; Fontana F; Hernandez-Aya LF; Kobayashi T; Tomasson HM; Su J; Bakewell SJ; Stewart SA; Egbulefu C; Karmakar P; Meyer MA; Veis DJ; DeNardo DG; Lanza GM; Achilefu S; Weilbaecher KN
    J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34520398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
    Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
    J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of Kruppel-like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid-derived suppressor cells.
    Yu F; Shi Y; Wang J; Li J; Fan D; Ai W
    Int J Cancer; 2013 Dec; 133(12):2872-83. PubMed ID: 23737434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade.
    Aaboe Jørgensen M; Ugel S; Linder Hübbe M; Carretta M; Perez-Penco M; Weis-Banke SE; Martinenaite E; Kopp K; Chapellier M; Adamo A; De Sanctis F; Frusteri C; Iezzi M; Zocca MB; Hargbøll Madsen D; Wakatsuki Pedersen A; Bronte V; Andersen MH
    Cancer Immunol Res; 2021 Nov; 9(11):1316-1326. PubMed ID: 34518197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.
    Kohanbash G; McKaveney K; Sakaki M; Ueda R; Mintz AH; Amankulor N; Fujita M; Ohlfest JR; Okada H
    Cancer Res; 2013 Nov; 73(21):6413-23. PubMed ID: 24030977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment.
    Yan WL; Wu CC; Shen KY; Liu SJ
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric antigen receptor T cells shape myeloid cell function within the tumor microenvironment through IFN-γ and GM-CSF.
    Spear P; Barber A; Rynda-Apple A; Sentman CL
    J Immunol; 2012 Jun; 188(12):6389-98. PubMed ID: 22586039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment.
    Jesser EA; Brady NJ; Huggins DN; Witschen PM; O'Connor CH; Schwertfeger KL
    Breast Cancer Res; 2021 Nov; 23(1):104. PubMed ID: 34743736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients.
    Khanna S; Graef S; Mussai F; Thomas A; Wali N; Yenidunya BG; Yuan C; Morrow B; Zhang J; Korangy F; Greten TF; Steinberg SM; Stetler-Stevenson M; Middleton G; De Santo C; Hassan R
    Clin Cancer Res; 2018 Jun; 24(12):2859-2872. PubMed ID: 29602801
    [No Abstract]   [Full Text] [Related]  

  • 10. Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression.
    Reggiani F; Labanca V; Mancuso P; Rabascio C; Talarico G; Orecchioni S; Manconi A; Bertolini F
    Cancer Res; 2017 Sep; 77(18):5169-5182. PubMed ID: 28754674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
    Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
    Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
    Morales JK; Kmieciak M; Knutson KL; Bear HD; Manjili MH
    Breast Cancer Res Treat; 2010 Aug; 123(1):39-49. PubMed ID: 19898981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARγ Contributes to Immunity Induced by Cancer Cell Vaccines That Secrete GM-CSF.
    Goyal G; Wong K; Nirschl CJ; Souders N; Neuberg D; Anandasabapathy N; Dranoff G
    Cancer Immunol Res; 2018 Jun; 6(6):723-732. PubMed ID: 29669721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity.
    Miret JJ; Kirschmeier P; Koyama S; Zhu M; Li YY; Naito Y; Wu M; Malladi VS; Huang W; Walker W; Palakurthi S; Dranoff G; Hammerman PS; Pecot CV; Wong KK; Akbay EA
    J Immunother Cancer; 2019 Feb; 7(1):32. PubMed ID: 30728077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M-MDSC
    Aintablian A; Strozniak S; Heuer M; Lutz MB
    Front Immunol; 2023; 14():1130600. PubMed ID: 37275910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression.
    Cao P; Sun Z; Zhang F; Zhang J; Zheng X; Yu B; Zhao Y; Wang W; Wang W
    Front Immunol; 2022; 13():919674. PubMed ID: 35874674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid cells in circulation and tumor microenvironment of breast cancer patients.
    Toor SM; Syed Khaja AS; El Salhat H; Faour I; Kanbar J; Quadri AA; Albashir M; Elkord E
    Cancer Immunol Immunother; 2017 Jun; 66(6):753-764. PubMed ID: 28283696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity.
    Ruffolo LI; Jackson KM; Kuhlers PC; Dale BS; Figueroa Guilliani NM; Ullman NA; Burchard PR; Qin SS; Juviler PG; Keilson JM; Morrison AB; Georger M; Jewell R; Calvi LM; Nywening TM; O'Dell MR; Hezel AF; De Las Casas L; Lesinski GB; Yeh JJ; Hernandez-Alejandro R; Belt BA; Linehan DC
    Gut; 2022 Jul; 71(7):1386-1398. PubMed ID: 34413131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
    Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
    Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF derived from the inflammatory microenvironment potentially enhanced PD-L1 expression on tumor-associated macrophages in human breast cancer.
    Yonemitsu K; Pan C; Fujiwara Y; Miyasato Y; Shiota T; Yano H; Hosaka S; Tamada K; Yamamoto Y; Komohara Y
    Sci Rep; 2022 Jul; 12(1):12007. PubMed ID: 35835809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.